About
Cradle develops a generative AI platform for de novo protein design, enabling researchers to create and optimize proteins with desired properties. Their technology utilizes machine learning models trained on proprietary and user-supplied experimental data to generate novel protein sequences and predict their characteristics, accelerating the drug discovery and protein engineering processes. Cradle targets biotechnology and pharmaceutical companies, and their platform aims to reduce the time and cost associated with traditional protein development pipelines by minimizing the need for iterative lab experiments.
Focus Areas
Technology Focus
drug discovery generative ai scientific ai
Quick Stats
Total Raised $100M
Founded 2021
Status private
Type startup
Explore More
Similar Companies
Insilico Medicine
Hong Kong, Hong Kong
63%
2 shared categories
2 shared AI types
Generative AIDrug Discovery
Genesis Therapeutics
Burlingame, United States
63%
2 shared categories
2 shared AI types
Drug DiscoveryGenerative AI
EvolutionaryScale
New York, United States
63%
2 shared categories
2 shared AI types
Drug DiscoveryProtein Engineering
Tempus AI
Chicago, United States
58%
2 shared categories
2 shared AI types
Generative AIDrug Discovery